Casandra
Casandra Test Code NG33389Version 1 (DRAFT)
Performing Lab
BRCA2 Single Gene (Germline)
Clinical Use
Order TestUse
This germline test targets BRCA2, a high‑penetrance gene associated with hereditary breast and ovarian cancer risk. Identification of pathogenic variants in BRCA2 can inform patient and familial cancer risk, guide surveillance, and influence treatment decisions, including eligibility for PARP inhibitor therapy.
Special Instructions
Testing is performed by Fulgent Genetics as a send‑out.
Limitations
Not provided.
Test Details
New York Approved
Methodology
NGS
Biomarkers
BRCA2
GeneSNV/Indel • Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
null-37 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
two x 4 mL
Minimum Volume
Not provided
Container
EDTA tube
Storage Instructions
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.